Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

New EMA product specific guidance (PSG) [BE/BA News]

posted by SMA – Europe, 2024-01-16 10:51 (540 d 07:07 ago) – Posting: # 23828
Views: 3,783
(edited on 2024-01-16 11:07)

Dear all

EMA has published two new PSGs:

Azacitidine powder for suspension for injection 25 mg/ml product-specific bioequivalence guidance (here)
Paliperidone palmitate depot suspension for injection (every 3 months) 175, 263, 350 and 525 mg product-specific bioequivalence guidance (here)

Consultations open until 2024-04-30

Complete thread:

New EMA product specific guidance (PSG)SMA 2024-01-16 09:51
- New EMA product specific guidance (PSG) dshah 2024-01-17 10:12

Admin contact
23,428 posts in 4,929 threads, 1,689 registered users;
49 visitors (0 registered, 49 guests [including 7 identified bots]).
Forum time: 18:58 CEST (Europe/Vienna)

If I’d observed all the rules,
I’d never have got anywhere. Marilyn Monroe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz